Airway Inspector: a chest imaging biomarker software platform for COPD

Airway Inspector:用于 COPD 的胸部成像生物标志物软件平台

基本信息

  • 批准号:
    8421710
  • 负责人:
  • 金额:
    $ 44.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-01-14 至 2017-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chronic Obstructive Pulmonary Disease affects up to 24 million people in the United States and is projected to be the 3rd leading cause of death worldwide by 2020. COPD has been traditionally dichotomized into the clinical phenotypes of emphysema and chronic bronchitis. Although spirometry is critical for diagnosis of COPD, FEV1 may be of limited value in a classification scheme designed to illuminate differences in disease mechanism among individuals." Computed tomographic (CT) imaging of the lung is a tool that may fulfill the need of new biomarkers to: facilitate the creation and testing of novel therapies, act as surrogate endpoints for clinical trials and provide researchers with the ability to reduce the heterogeneity of a cohort of subjects with COPD into more homogeneous subgroups to assist in monitoring study endpoints Airway Inspector is a open source software tool based on Slicer 2.x developed at Brigham and Women's Hospital for the analysis of chest CT scans for the analysis of emphysema and airway disease. The tool was conceived to analysis low resolution CT scans bringing the gap between retrospective data and new emerging CT technologies. The success of the tool in the COPD clinical community is supported by the array of peer- review publications that have used the tool to define metrics of disease that enable hypothesis driven research. Beside the existence of alternative commercial applications, Airway Inspector is the only freely available maintained platform for COPD research. In spite of its success, Airway Inspector is limited to a discontinued version of Slicer. The broad objective of this proposal is to support the refactoring and development of Airway Inspector as a platform for image-based COPD research. This goal will be achieved by the creation of the Chest Imaging Biomarker Platform (CIBP) library that integrates novel algorithm solutions to lung image analysis that have been developed in our laboratory. Those solutions include: robust lung extraction, parenchymal tissue classification based on local density, airway, fissure and pulmonary vascular extraction based on scale-space particles and airway labeling based on Hidden Markov Models. That software platform will be used to create workflows that will be integrated in Slicer 4 for their deployment in the clinical community. Slicer 4 is a NIH supported open software general purpose imaging software platform that is specifically designed to integrate solutions like Airway Inspector. The workflows will provide an end-to-end solution for the clinical to obtain phenotypes to characterize emphysema, airway disease and pulmonary vascular remodeling.
描述(由申请人提供):慢性阻塞性肺疾病影响美国多达2400万人,预计到2020年将成为全球第三大死亡原因。COPD传统上被分为肺气肿和慢性支气管炎的临床表型。尽管肺功能测定对COPD的诊断至关重要,但FEV1在旨在阐明个体间疾病机制差异的分类方案中的价值可能有限。“肺部的计算机断层扫描(CT)成像是一种工具,可以满足新生物标志物的需求,以:促进新疗法的创造和测试,作为临床试验的替代终点,并为研究人员提供将COPD受试者队列的异质性降低为更同质的亚组的能力,以协助监测研究终点Airway Inspector是一种开源软件工具,在Brigham and Women's Hospital开发的Slicer 2.x用于分析胸部CT扫描,以分析肺气肿和气道疾病。该工具旨在分析低分辨率CT扫描,从而弥补回顾性数据与新兴CT技术之间的差距。该工具在COPD临床社区的成功得到了一系列同行评审出版物的支持,这些出版物使用该工具定义了能够进行假设驱动研究的疾病指标。除了存在替代商业应用外,Airway Inspector是COPD研究的唯一免费维护平台。尽管取得了成功,Airway Inspector仅限于Slicer的停产版本。该提案的主要目标是支持Airway Inspector的重构和开发,使其成为基于图像的COPD研究平台。这一目标将通过创建胸部成像生物标志物平台(CIBP)库来实现,该库将我们实验室开发的新颖算法解决方案集成到肺部图像分析中。这些解决办法包括:鲁棒的肺提取、基于局部密度的实质组织分类、基于尺度空间粒子的气道、裂隙和肺血管提取以及基于隐马尔可夫模型的气道标记。该软件平台将用于创建工作流程,这些工作流程将集成到Slicer 4中,以便在临床社区中部署。Slicer 4是NIH支持的开放软件通用成像软件平台,专门设计用于集成Airway Inspector等解决方案。这些工作流程将为临床提供端到端的解决方案,以获得表征肺气肿、气道疾病和肺血管重塑的表型。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Raul San Jose Estepar其他文献

Raul San Jose Estepar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Raul San Jose Estepar', 18)}}的其他基金

Contributions of pulmonary arterial and venous remodeling to HFpEF in the elderly
肺动脉和静脉重构对老年人 HFpEF 的影响
  • 批准号:
    10446349
  • 财政年份:
    2022
  • 资助金额:
    $ 44.03万
  • 项目类别:
Contributions of pulmonary arterial and venous remodeling to HFpEF in the elderly
肺动脉和静脉重构对老年人 HFpEF 的影响
  • 批准号:
    10621906
  • 财政年份:
    2022
  • 资助金额:
    $ 44.03万
  • 项目类别:
CT and CXR Phenotyping Platform for Assessing COVID-19 Susceptibility and Severity
用于评估 COVID-19 敏感性和严重程度的 CT 和 CXR 表型平台
  • 批准号:
    10382425
  • 财政年份:
    2021
  • 资助金额:
    $ 44.03万
  • 项目类别:
CT and CXR Phenotyping Platform for Assessing COVID-19 Susceptibility and Severity
用于评估 COVID-19 敏感性和严重程度的 CT 和 CXR 表型平台
  • 批准号:
    10196276
  • 财政年份:
    2021
  • 资助金额:
    $ 44.03万
  • 项目类别:
Prognostic Markers of Emphysema Progression
肺气肿进展的预后标志物
  • 批准号:
    10368048
  • 财政年份:
    2020
  • 资助金额:
    $ 44.03万
  • 项目类别:
Prognostic Markers of Emphysema Progression
肺气肿进展的预后标志物
  • 批准号:
    10593186
  • 财政年份:
    2020
  • 资助金额:
    $ 44.03万
  • 项目类别:
The clinical impact of pulmonary vascular remodeling in smokers
吸烟者肺血管重塑的临床影响
  • 批准号:
    8418060
  • 财政年份:
    2013
  • 资助金额:
    $ 44.03万
  • 项目类别:
Airway Inspector: a chest imaging biomarker software platform for COPD
Airway Inspector:用于 COPD 的胸部成像生物标志物软件平台
  • 批准号:
    8605217
  • 财政年份:
    2013
  • 资助金额:
    $ 44.03万
  • 项目类别:
The clinical impact of pulmonary vascular remodeling in smokers
吸烟者肺血管重塑的临床影响
  • 批准号:
    8793809
  • 财政年份:
    2013
  • 资助金额:
    $ 44.03万
  • 项目类别:
The clinical impact of longitudinal measures of cardiac and pulmonary vascular morphology in smokers
吸烟者心脏和肺血管形态纵向测量的临床影响
  • 批准号:
    9982372
  • 财政年份:
    2013
  • 资助金额:
    $ 44.03万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 44.03万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 44.03万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.03万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.03万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.03万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 44.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 44.03万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 44.03万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 44.03万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 44.03万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了